Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,223,323 papers from all fields of science
Search
Sign In
Create Free Account
CEBPE protein, human
Known as:
C/EBP Epsilon
, CEBPE
, C-EBP epsilon protein, human
Expand
CCAAT/enhancer-binding protein epsilon (281 aa, ~31 kDa) is encoded by the human CEBPE gene. This protein plays a role in transcriptional regulation.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
16 relations
Broader (1)
CCAAT-Enhancer-Binding Proteins
CCAAT/Enhancer Binding Protein Alpha
CEBPA gene
CEBPE gene
CEBPE wt Allele
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
Sun-Mi Park
,
Hyunwoo Cho
,
+15 authors
M. Kharas
Cell Stem Cell
2019
Corpus ID: 53754637
2019
2019
Identification of a novel enhancer of CEBPE essential for granulocytic differentiation.
P. Shyamsunder
,
Mahalakshmi Shanmugasundaram
,
+12 authors
H. Koeffler
Blood
2019
Corpus ID: 96449802
CCAAT/enhancer binding protein ε (CEBPE) is an essential transcription factor for granulocytic differentiation. Mutations of…
Expand
2018
2018
CARD10, a CEBPE target involved in granulocytic differentiation
P. Shyamsunder
,
Haresh Sankar
,
+7 authors
H. Koeffler
Haematologica
2018
Corpus ID: 21693883
Maturation of granulocytes is dependent on controlled gene expression by myeloid lineage restricted transcription factors. CEBPE…
Expand
2018
2018
Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell Lines
Aleksandra Marchwicka
,
E. Marcinkowska
International Journal of Molecular Sciences
2018
Corpus ID: 49649536
All-trans-retinoic acid (ATRA) and 1α,25-dihydroxyvitamin D (1,25D) are potent inducers of differentiation of myeloid leukemia…
Expand
2015
2015
Nicotinamide Exacerbates Hypoxemia in Ventilator-Induced Lung Injury Independent of Neutrophil Infiltration
H. Jones
,
J. Yoo
,
+8 authors
K. Shimada
PLoS ONE
2015
Corpus ID: 52800375
Background Ventilator-induced lung injury is a form of acute lung injury that develops in critically ill patients on mechanical…
Expand
2015
2015
Correction: Nicotinamide Exacerbates Hypoxemia in Ventilator-Induced Lung Injury Independent of Neutrophil Infiltration
H. Jones
,
J. Yoo
,
+8 authors
K. Shimada
PLoS ONE
2015
Corpus ID: 16170673
1 Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America, 2…
Expand
2014
2014
miRNA-130a regulates C/EBP-ε expression during granulopoiesis.
M. T. Larsen
,
M. Häger
,
+5 authors
J. Cowland
Blood
2014
Corpus ID: 5615052
CCAAT/enhancer binding protein-ε (C/EBP-ε) is considered a master transcription factor regulating terminal neutrophil maturation…
Expand
2013
2013
Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation
K. Ng
,
Z. Hu
,
Q. Ebrahem
,
S. Negrotto
,
J. Lausen
,
Y. Saunthararajah
Oncogenesis
2013
Corpus ID: 10952418
First-hits in the multi-hit process of leukemogenesis originate in germline or hematopoietic stem cells (HSCs), yet leukemia…
Expand
2011
2011
Double CEBPE-IGH rearrangement due to chromosome duplication and cryptic insertion in an adult with B-cell acute lymphoblastic leukemia.
V. Pierini
,
Valeria Nofrini
,
+9 authors
C. Mecucci
Cancer Genetics
2011
Corpus ID: 35669559
Highly Cited
2006
Highly Cited
2006
Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes
I. Nagaev
,
M. Bokarewa
,
A. Tarkowski
,
U. Smith
PLoS ONE
2006
Corpus ID: 9033348
The characteristics of human resistin (RETN) are unclear and controversial despite intensive adipose-focused research. Its…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE